DEL Bulletin LEPP No. 79 Information to Market Authorization Holders (MAHs) of Human Pharmaceutical Products Regarding Nitrosamine Impurities

Posted Date: 31-March-2020

FDA Issues FY2023 Report on the State of Pharmaceutical Quality

Posted By:  Linitha Ganesh

Please login to view this content.